ZURICH (Reuters) – Novartis ( NOVN.S ) on Friday disputed a report from Democratic U.S. senators that concluded the Swiss drugmaker misled the public about its $1.2 million contract with a former attorney for President Donald Trump. FILE PHOTO: Swiss drugmaker Novartis’ logo is seen at the company’s plant […]

Click here to view original web page at www.reuters.com